News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News Samsung Bioepis files Herceptin biosimilar in EU South Korean firm trying to copy breast cancer blockbuster.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
